Posted inBusiness Dr. Reddy’s Delays Semaglutide Rollout Following Quality Control Concerns Dr. Reddy's halts semaglutide launch due to quality concerns, impacting shares and the race for generic weight-loss and diabetes treatments. Posted by srkanalytics.srk@gmail.com July 9, 2026
